INDOCO Q1 FY27 results at a glance
INDOCO REMEDIES LTD. Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹466 cr |
|---|
| Revenue YoY | +8.2% |
|---|
| Operating profit | ₹6.49 cr |
|---|
| Operating margin | 1.4% |
|---|
| Net profit | ₹64.99 cr |
|---|
| Net profit YoY | +281.6% |
|---|
| Net profit QoQ | +400.3% |
|---|
| Net margin | 13.9% |
|---|
| Basic EPS | ₹7.09 |
|---|
| TTM revenue | ₹1,828 cr |
|---|
| TTM net profit | ₹5.63 cr |
|---|
| TTM net margin | 0.3% |
|---|
INDOCO Q1 FY27 results: what the numbers say
INDOCO REMEDIES LTD. (INDOCO) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹466 cr and a net profit of ₹64.99 cr, translating into earnings per share of ₹7.09.
Compared with the same quarter a year earlier, revenue grew by +8.2% and net profit grew sharply by +281.6%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹6.49 cr, an operating margin of 1.4% versus -2.8% a year ago — a gain of 4.2 percentage points.
INDOCO quarter-wise results table
Net profit
₹64.99 cr
+281.6% YoY
Operating profit
₹6.49 cr
+153.3% YoY
INDOCO REMEDIES LTD. (INDOCO) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹466 cr | ₹6.49 cr | ₹64.99 cr | 1.4% | 13.9% | ₹7.09 | +281.6% | +400.3% |
| Q4 FY262026-03-31 | ₹456 cr | ₹17.22 cr | -₹21.64 cr | 3.8% | -4.7% | ₹-2.57 | — | +27.4% |
| Q3 FY262025-12-31 | ₹434 cr | -₹0.5 cr | -₹29.79 cr | -0.1% | -6.9% | ₹-3.20 | — | -275.7% |
| Q2 FY262025-09-30 | ₹472 cr | ₹10.8 cr | -₹7.93 cr | 2.3% | -1.7% | ₹-1.00 | — | +77.8% |
| Q1 FY262025-06-30 | ₹431 cr | -₹12.17 cr | -₹35.79 cr | -2.8% | -8.3% | ₹-3.94 | — | — |
| TTM (last 4 quarters) | ₹1,828 cr | ₹34.01 cr | ₹5.63 cr | 1.9% | 0.3% | ₹0.32 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
INDOCO quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
INDOCO REMEDIES LTD. quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹466 cr | ₹456 cr | ₹434 cr | ₹472 cr | ₹431 cr |
|---|
| Total expenses | ₹460 cr | ₹439 cr | ₹435 cr | ₹461 cr | ₹443 cr |
|---|
| Gross profit | ₹308 cr | ₹315 cr | ₹314 cr | ₹326 cr | ₹296 cr |
|---|
| Operating profit (EBIT) | ₹6.49 cr | ₹17.22 cr | -₹0.5 cr | ₹10.8 cr | -₹12.17 cr |
|---|
| Operating margin | 1.4% | 3.8% | -0.1% | 2.3% | -2.8% |
|---|
| Interest cost | ₹28.29 cr | ₹45.92 cr | ₹25.64 cr | ₹24.56 cr | ₹26.12 cr |
|---|
| Profit before tax | ₹77.72 cr | -₹25 cr | -₹31.31 cr | -₹13.53 cr | -₹36.66 cr |
|---|
| Tax expense | ₹12.28 cr | -₹1.32 cr | -₹1.86 cr | -₹4.32 cr | -₹0.31 cr |
|---|
| Effective tax rate | 15.8% | 5.3% | 5.9% | 31.9% | 0.8% |
|---|
| Net profit (PAT) | ₹64.99 cr | -₹21.64 cr | -₹29.79 cr | -₹7.93 cr | -₹35.79 cr |
|---|
| Net profit margin | 13.9% | -4.7% | -6.9% | -1.7% | -8.3% |
|---|
| Basic EPS | ₹7.09 | ₹-2.57 | ₹-3.20 | ₹-1.00 | ₹-3.94 |
|---|
| Diluted EPS | ₹7.09 | ₹-2.57 | ₹-3.20 | ₹-1.00 | ₹-3.94 |
|---|
INDOCO results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +8.2% | — | — | — | — |
|---|
| Revenue QoQ | +2.3% | +5.0% | -7.9% | +9.5% | — |
|---|
| Operating profit YoY | +153.3% | — | — | — | — |
|---|
| Operating profit QoQ | -62.3% | +3544.0% | -104.6% | +188.7% | — |
|---|
| Net profit YoY | +281.6% | — | — | — | — |
|---|
| Net profit QoQ | +400.3% | +27.4% | -275.7% | +77.8% | — |
|---|
| EPS YoY | +279.9% | — | — | — | — |
|---|
| EPS QoQ | +375.9% | +19.7% | -220.0% | +74.6% | — |
|---|
INDOCO annual results history
Full-year performance for INDOCO REMEDIES LTD., useful for reading each quarter in context.
INDOCO REMEDIES LTD. annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹1,793 cr | ₹1,641 cr | ₹1,788 cr | ₹1,640 cr |
|---|
| Total expenses | ₹1,778 cr | ₹1,656 cr | ₹1,645 cr | ₹1,442 cr |
|---|
| Gross profit | ₹1,251 cr | ₹1,143 cr | ₹1,206 cr | ₹1,101 cr |
|---|
| Operating profit (EBIT) | ₹15.35 cr | -₹14.58 cr | ₹143 cr | ₹198 cr |
|---|
| Operating margin | 0.9% | -0.9% | 8.0% | 12.1% |
|---|
| Interest cost | ₹122 cr | ₹66.23 cr | ₹34.93 cr | ₹23.75 cr |
|---|
| Profit before tax | -₹107 cr | -₹74.37 cr | ₹136 cr | ₹193 cr |
|---|
| Tax expense | -₹7.81 cr | ₹3.58 cr | ₹38.79 cr | ₹50.54 cr |
|---|
| Effective tax rate | 7.3% | -4.8% | 28.6% | 26.2% |
|---|
| Net profit (PAT) | -₹95.15 cr | -₹73.74 cr | ₹98.46 cr | ₹142 cr |
|---|
| Net profit margin | -5.3% | -4.5% | 5.5% | 8.7% |
|---|
| Basic EPS | ₹-10.31 | ₹-8.00 | ₹10.68 | ₹15.44 |
|---|
| Diluted EPS | ₹-10.31 | ₹-8.00 | ₹10.67 | ₹15.42 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹466 cr against ₹431 cr in Q1 FY26, and ₹456 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +2.3%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹460 cr, or 98.6% of revenue, with operating profit grew +153.3% year on year.
Margins, tax and profitability
Net profit of ₹64.99 cr works out to a net margin of 13.9% compared with -8.3% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, INDOCO REMEDIES LTD. reported profit before tax of ₹77.72 cr, a tax charge of ₹12.28 cr (effective rate 15.8%), interest cost of ₹28.29 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from -₹21.64 cr in Q4 FY26 to ₹64.99 cr in Q1 FY27, a change of +400.3%.
Trailing twelve months and annual context
Across the trailing four quarters INDOCO REMEDIES LTD. has generated revenue of ₹1,828 cr and net profit of ₹5.63 cr, a trailing net margin of 0.3%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹1,793 cr with net profit of -₹95.15 cr and EPS of ₹-10.31, versus the prior year where revenue grew +9.2% and profit declined -29.0%.
What to watch in the next INDOCO quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
INDOCO REMEDIES LTD. has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
INDOCO results coverage
No results report published for INDOCO yet — our desk covers each quarter within minutes of the filing.
More on INDOCO
INDOCO quarterly results FAQs
What were INDOCO REMEDIES LTD. (INDOCO) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), INDOCO REMEDIES LTD. reported revenue of ₹466 cr and net profit of ₹64.99 cr, a change of +281.6% year on year on +8.2% revenue growth. EPS stood at ₹7.09.
What is INDOCO profit margin in Q1 FY27?
INDOCO REMEDIES LTD. posted a net profit margin of 13.9% and an operating margin of 1.4% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹1,828 cr and net profit ₹5.63 cr.
Did INDOCO results beat the previous quarter?
INDOCO REMEDIES LTD. net profit changed +400.3% quarter on quarter, from -₹21.64 cr in Q4 FY26 to ₹64.99 cr in Q1 FY27.
When are INDOCO REMEDIES LTD. (INDOCO) quarterly results?
INDOCO REMEDIES LTD. has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see INDOCO latest quarterly results?
Results coverage for INDOCO will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the INDOCO stock page.
What is INDOCO REMEDIES LTD. annual revenue and profit?
For FY26, INDOCO REMEDIES LTD. reported full-year revenue of ₹1,793 cr and net profit of -₹95.15 cr, with EPS of ₹-10.31.
How many quarterly results has INDOCO declared recently?
Past results dates for INDOCO will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 11 Sept 2026. For information only, not investment advice.
